News & Media

The Weizmann Institute and the Max Planck Society have launched a center to study humankind’s history in new ways, such as by using sophisticated technologies borrowed from physics.

January 11, 2012

Prof. Irit Sagi has successfully tricked the immune system into targeting an enzyme involved in the autoimmune process. Her synthetic molecules could lead to new treatments for Crohn’s and other autoimmune diseases.

December 26, 2011

From: Bloomberg Business Week

Teva Pharmaceutical Industries Ltd., the world’s largest generic-drug maker, is seeking to transform a compound once rejected by Sanofi into the first treatment to succeed insulin for Type 1 diabetes.

December 20, 2011

From: Nature

The US humorist Evan Esar once called statistics the science of producing unreliable facts from reliable figures. An innovative technique now promises to make those facts a whole lot more dependable.

December 15, 2011

From: The Jerusalem Post

Weizmann Institute of Science astrophysicists have been prominent in the experiments that have shown “promising signs” of the existence of the Higgs boson – the “God particle” – that provides a framework for all of the subatomic particles in nature and has been sought for decades.

December 14, 2011

The LHC at CERN in Geneva announced that it has seen “tantalizing hints” of the possible existence of the Higgs boson. Weizmann physicists have been key members of this search since 1987.

December 13, 2011

The holiday season can be full of less-than-joyful issues such as stress and overeating. Weizmann scientists are studying related topics like obesity, metabolic disorders, and the body’s stress response.

December 11, 2011

From: Scientific America

Performance usually improves with practice, but not if training is a rotten time. A new study shows that people’s ability to identify noises declines when the sounds are paired with putrid smells–a phenomenon that may allow our brain to detect danger more quickly.

December 09, 2011

Three updates from the Weizmann Institute: performing secure cloud computing; evidence that endothelial cells may actively direct immune cells; and a possible new scenario for supernova development.

December 01, 2011

Patients with Type 1 diabetes who were treated with DiaPep277® in clinical trials saw benefits. Weizmann’s Prof. Irun Cohen developed the novel drug.

November 22, 2011